Abstract Introduction The superior efficacy and safety of semaglutide once-weekly (QW), compared with dulaglutide, liraglutide, or exenatide QW, have been demonstrated in the SUSTAIN trials
The research, clinical development, testing, quality control, safety, effectiveness, manufacturing, labeling, packaging, storage, record-keeping, advertising, promotion, marketing, import, export, distribution, post-approval monitoring, and post-approval reporting of our product candidates are subject to extensive regulation by the FDA in the United States and by comparable foreign regulatory authorities in foreign markets
Reiss RF, Gray Jr GF
In contrast, the hyposecretion of corticosteroids can result in Addisons disease, a rare disorder that causes low blood glucose levels and low blood sodium levels
Duplicate items were deleted